These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23231881)

  • 61. Role of mTOR Complex 1 Signaling Pathway in the Pathogenesis of Diabetes Complications; A Mini Review.
    Yarahmadi A; Azarpira N; Mostafavi-Pour Z
    Int J Mol Cell Med; 2021; 10(3):181-189. PubMed ID: 35178356
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ROCK 'n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition.
    Centonze G; Centonze S; Ponzone L; Calautti E
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roles of mTOR Signaling in Brain Development.
    Lee DY
    Exp Neurobiol; 2015 Sep; 24(3):177-85. PubMed ID: 26412966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unitary Physiology.
    Torday JS; Miller WB
    Compr Physiol; 2018 Mar; 8(2):761-771. PubMed ID: 29687904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T memory stem cell formation: Caveat mTOR.
    Fowler DH; Gattinoni L
    EBioMedicine; 2016 Feb; 4():3-4. PubMed ID: 26981558
    [No Abstract]   [Full Text] [Related]  

  • 66. mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions.
    Showkat M; Beigh MA; Andrabi KI
    Mol Biol Int; 2014; 2014():686984. PubMed ID: 25505994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. mTOR pathway inhibition alters proliferation as well as differentiation of neural stem cells.
    Romanyuk N; Sintakova K; Arzhanov I; Horak M; Gandhi C; Jhanwar-Uniyal M; Jendelova P
    Front Cell Neurosci; 2024; 18():1298182. PubMed ID: 38812794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
    Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The STAT3-Regulated Autophagy Pathway in Glioblastoma.
    Laribee RN; Boucher AB; Madireddy S; Pfeffer LM
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy.
    Bouyahya A; El Allam A; Aboulaghras S; Bakrim S; El Menyiy N; Alshahrani MM; Al Awadh AA; Benali T; Lee LH; El Omari N; Goh KW; Ming LC; Mubarak MS
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428613
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study.
    Ieni A; Pizzimenti C; Broggi G; Caltabiano R; Germanò A; Barbagallo GMV; Vigneri P; Giuffrè G; Tuccari G
    Oncol Lett; 2022 Oct; 24(4):336. PubMed ID: 36039055
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma.
    Wu H; Wei M; Li Y; Ma Q; Zhang H
    Front Mol Neurosci; 2022; 15():910543. PubMed ID: 35935338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells.
    Bhattacharya S; Yin J; Yang C; Wang Y; Sims M; Pfeffer LM; Chaum E
    J Cell Mol Med; 2022 Jul; 26(14):3873-3890. PubMed ID: 35670018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity.
    Ryskalin L; Ferese R; Morucci G; Biagioni F; Busceti CL; Michetti F; Lenzi P; Frati A; Fornai F
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma.
    Amin AG; Jeong SW; Gillick JL; Sursal T; Murali R; Gandhi CD; Jhanwar-Uniyal M
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34523696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rapamycin Ameliorates Defects in Mitochondrial Fission and Mitophagy in Glioblastoma Cells.
    Lenzi P; Ferese R; Biagioni F; Fulceri F; Busceti CL; Falleni A; Gambardella S; Frati A; Fornai F
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway.
    Lv S; Yuan P; Lu C; Dong J; Li M; Qu F; Zhu Y; Zhang J
    Aging (Albany NY); 2021 Feb; 13(4):5525-5538. PubMed ID: 33582656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma.
    Khan I; Baig MH; Mahfooz S; Rahim M; Karacam B; Elbasan EB; Ulasov I; Dong JJ; Hatiboglu MA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatic Tumor Cell Morphology Plasticity under Physical Constraints in 3D Cultures Driven by YAP-mTOR Axis.
    Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Hof M; Jurkiewicz P; Lozinsky VI; Wolfová L; Petrenko Y; Kubinová Š; Dejneka A; Lunov O
    Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33260691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Autophagy: a promising therapeutic target for improving mesenchymal stem cell biological functions.
    Deng J; Zhong L; Zhou Z; Gu C; Huang X; Shen L; Cao S; Ren Z; Zuo Z; Deng J; Yu S
    Mol Cell Biochem; 2021 Feb; 476(2):1135-1149. PubMed ID: 33196943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.